Daiichi Sankyo Company, Limited (DSKYF)

USD 26.5

(0.0%)

Total Debt Summary of Daiichi Sankyo Company, Limited

  • Daiichi Sankyo Company, Limited's latest annual total debt in 2024 was 156 Billion JPY , down -47.26% from previous year.
  • Daiichi Sankyo Company, Limited's latest quarterly total debt in 2024 FY was 156 Billion JPY , down -19.11% from previous quarter.
  • Daiichi Sankyo Company, Limited reported annual total debt of 192.85 Billion JPY in 2023, down -9.72% from previous year.
  • Daiichi Sankyo Company, Limited reported annual total debt of 213.61 Billion JPY in 2022, down -5.55% from previous year.
  • Daiichi Sankyo Company, Limited reported quarterly total debt of 156 Billion JPY for 2024 FY, down -19.11% from previous quarter.
  • Daiichi Sankyo Company, Limited reported quarterly total debt of 101.9 Billion JPY for 2024 Q2, down -28.74% from previous quarter.

Annual Total Debt Chart of Daiichi Sankyo Company, Limited (2024 - 2000)

Historical Annual Total Debt of Daiichi Sankyo Company, Limited (2024 - 2000)

Year Total Debt Total Debt Growth
2024 156 Billion JPY -47.26%
2023 192.85 Billion JPY -9.72%
2022 213.61 Billion JPY -5.55%
2021 226.17 Billion JPY -15.08%
2020 266.33 Billion JPY 1.68%
2019 261.92 Billion JPY -7.15%
2018 282.1 Billion JPY -0.01%
2017 282.14 Billion JPY 38.57%
2016 203.61 Billion JPY -8.04%
2015 221.42 Billion JPY -47.73%
2014 423.61 Billion JPY 58.77%
2013 266.81 Billion JPY -2.96%
2012 274.94 Billion JPY -8.17%
2011 299.39 Billion JPY 2.92%
2010 290.91 Billion JPY -11.11%
2009 327.27 Billion JPY 380456.98%
2008 86 Million JPY -99.15%
2007 10.09 Billion JPY -40.36%
2006 16.92 Billion JPY -15.69%
2005 20.07 Billion JPY -0.87%
2004 20.24 Billion JPY -1.97%
2003 20.65 Billion JPY 0.0%
2002 - JPY 0.0%
2001 - JPY 0.0%
2000 - JPY 0.0%

Peer Total Debt Comparison of Daiichi Sankyo Company, Limited

Name Total Debt Total Debt Difference
AstraZeneca PLC 28.58 Billion USD -445.813%
Bristol-Myers Squibb Company PFD CONV 2 41.46 Billion USD -276.235%
CSPC Pharmaceutical Group Limited 99.64 Million USD -156456.248%
Clarus Therapeutics Holdings, Inc. 42.26 Million USD -368969.531%
Novartis AG 26.34 Billion USD -492.083%
PT Kalbe Farma Tbk. 40.4 Million USD -385988.48%